Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersFamily Medicine Physician in Belleville, MI
NPI: 1144474826Primary Practice Location
Wellhealth Medical Associates P C
265 Main St, Belleville, MI
Primary Employer
Wellhealth Medical Associates P C
wellhealthassociatesbv.com
HQ Phone
Get M.D. Sanjay's Phone Numberphone_androidMobile
Get M.D. Sanjay's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardKY State Medical License
MI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 31 | 61 |
| 2 | 80307Testing for presence of drug | 27 | 39 |
| 3 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 17 | 44 |
| 4 | J1885Injection, ketorolac tromethamine, per 15 mg | 16 | 74 |
| 5 | J2300Injection, nalbuphine hydrochloride, per 10 mg | 12 | 14 |
The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape.
Authors: Gilaad Kaplan, Charles Bernstein
Journal: J Can Assoc Gastroenterol
Publication Date: 2023-09-05
Authors: McGuinty, Michaeline, Angel, Jonathan B, Cooper, Curtis L, Cowan, Juthaporn, MacPherson, Paul A, Kumar, Ashok, Murthy, Sanjay, Sy, Richmond, Dennehy, Michelle, Tremblay, Nancy, Byrareddy, Siddappa N, Cameron, D William
Journal: BMJ Open
Publication Date: 2020-10-08
The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD.
Authors: Gilaad Kaplan, Charles Bernstein
Journal: J Can Assoc Gastroenterol
Publication Date: 2023-09-05
Lead Sponsor: waqqas.afif
Collaborators: AbbVie
Intervention / Treatment: BIOLOGICAL: Adalimumab
Lead Sponsor: Ottawa Hospital Research Institute
Collaborators: University of Toronto, University of Alberta, MOUNT SINAI HOSPITAL, Providence Health & Services, Thunder Bay Regional Health Sciences Centre, Health Sciences Centre, Winnipeg, Manitoba, Western University, Canada, Hamilton Health Sciences Corporation, Nova Scotia Health Authority, McGill University Health Centre/Research Institute of the McGill University Health Centre, Eastern Health, Royal Jubilee Hospital
Intervention / Treatment: DIAGNOSTIC_TEST: Intervention Group, DIAGNOSTIC_TEST: Control Group
